Skip to content
Australian biotech Vaxxas, which is developing patch dispensers for different diseases, announced earlier this month it has initiated a “Phase I clinical trial with […]
Vaxxas initiates clinical trial of its COVID-19 vaccine patch Read More »
Plans to put limits on the FDA’s Accelerated Approval pathway would reduce the number of new treatments hitting the market, with a particularly negative
The 2023 U.S. Farm Bill can help drive biomanufacturing by improving federal programs, according to testimony today before the Senate Agriculture Committee, given by
Farm Bill could make things better for biotech Read More »
Many US acute care hospitals have seen an increase in healthcare-associated infections (HAIs)—including serious drug-resistant threats—in 2021, in “contrast with the success in reducing
CDC reports significant rise in healthcare-associated infections Read More »
Saturday’s Adaptation and Agriculture Day at COP27, which focused on the need for food systems innovation (including biotech) to feed 8 billion people, conveyed
COP27: Adaptation is essential for tackling global food security Read More »
Christopher A. Viehbacher has been named president and chief executive officer of Biogen Inc. as well as a member of the board of directors,
Biogen appoints Christopher Viehbacher as CEO and president Read More »
Regenerative farming is not only beneficial for soil and crops “but also improves the nutritional value of conventionally grown plant and animal foods,” but
Regenerative farming must ‘triple’ to limit climate change, SMI report says Read More »
Paying for healthcare in the United States has been a challenging and controversial issue for years. In a landscape managed by private insurers, Medicaid,
To ensure access for all, healthcare payment models need innovation Read More »
A new biotech company says they can reverse the aging process in living cells by “flipping” DNA markers, helping us stay healthier longer, according
Biotech firm chasing ‘fountain of rejuvenation’ Read More »
A new, cross-sectional study on the prevalence of post-acute sequelae of SARS CoV-2 infection shows that women are almost twice as likely to experience
Women are twice as likely to have long COVID, says new research Read More »
